osimertinib
astrazeneca
['adaura', 'lcsm,(-blcsm)', 'osimertinib']
waiting for the os update in adaura? updated os (hr 0.47 95% ci 0.27-0.83, cut off feb 2021), one year from asco 2020 (cut off jan 2020) are available in the pmda's approval report (japanese, the blue line indicates osimertinib). #lcsm #esmo22 
Medical Oncologist, National Cancer Center Hospital, Lung Cancer Study Group @JCOG_official, Educational Committee @JSMO_official, @JLCS_OFFICIAL, @IASLC